Skip to main content

Month: January 2021

MDxHealth Launches Capital Increase and Provides Preliminary 2020 Financial Results

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAWNEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 04:00 p.m. CETIRVINE, CA, and HERSTAL, BELGIUM – 21 January 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage innovative molecular diagnostics company, announces the launch of a capital increase with the offering of new ordinary shares by means of a private placement via an accelerated bookbuild offering (the “Capital Increase“).Preliminary 2020 Financial ResultsMDxHealth ended the fourth quarter of 2020 with second consecutive sequential increase in billable volume for...

Continue reading

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit

BROSSARD, Quebec, Jan. 21, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that its quality management system continues to comply with the applicable regulatory requirements for medical devices.As part of the requirements for the commercialization of our flagship product CARA from Health Canada and the Food and Drug Agency in the US (FDA), DIAGNOS must undergo thorough statutory annual quality compliance audits under the Medical Device Single Audit Program (MDSAP). MDSAP is a comprehensive approach to quality management systems auditing among countries devoted to enhance the safety of medical devices.“I would like to take...

Continue reading

DIAGNOS complète avec succès l’audit ISO 13485 / PAUMM

BROSSARD, Québec, 21 janv. 2021 (GLOBE NEWSWIRE) — Diagnos inc. (« DIAGNOS », la « Société » ou « nous ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un leader dans le dépistage précoce de problèmes graves de santé grâce à sa technologie d’intelligence artificielle (IA) FLAIRE, annonce aujourd’hui que son système de gestion de la qualité continue de se conformer aux exigences règlementaires concernant les instruments médicaux applicables à DIAGNOS.Dans le cadre des exigences de Santé Canada et de la Food and Drug Administration (FDA) aux États-Unis relatives à la commercialisation de notre produit phare CARA, DIAGNOS doit obligatoirement se soumettre à un processus rigoureux d’audit annuel de conformité de son système de qualité, soit le Programme d’Audit Unique pour le Matériel Médical (PAUMM). Le PAUMM est une approche globale...

Continue reading

GTX Corp Signs Collaboration Agreement with Pawtocol

LOS ANGELES, CALIFORNIA, Jan. 21, 2021 (GLOBE NEWSWIRE) — GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of health and safety wearable GPS human and asset tracking systems, and a supplier of personal protective equipment (“PPE”), announced today it has signed a collaboration agreement with Pawtocol, a Miami based global online community for the pet industry.Under the agreement GTX will explore integrating IoT sensors and embedded tech to collect and share pet data, leveraging Pawtocol’s blockchain technology. GTX’s Rover Tracker, which is a GPS and NFC IoT device designed for the rapid recovery and profile identification of pets, will be the first device tested on the platform.Pawtocol’s blockchain technology provides users privacy and security features, including complete control of their data and the ability...

Continue reading

Aurskog Sparebank: Utstedelse av obligasjonslån

Aurskog Sparebank har åpnet et nytt flytende obligasjonslån ISIN NO0010920861 på 100 MNOK med første innbetaling 27. januar 2021. Obligasjonslånet har forfall 27. april 2026.Total ramme på lånet er 400 MNOK.Tilrettelegger var DNB Markets.Kontaktperson:Andreas H. GlendeAss. banksjef/CFOTelefon: 48 11 66 95Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Continue reading

REC Silicon – Presentation at the Pareto Securities Power and Renewable Energy Conference 2021

Oslo, Norway – January 21, 2021: REC Silicon ASA (REC Silicon)Please find attached the REC Silicon presentation given by Tore Torvund, REC Silicon CEO, at the Pareto Securities virtual Power and Renewable Energy Conference 2021 today.For further information, please contact:Nils O. KjerstadIR ContactPhone: +47 9135 6659Email: nils.kjerstad@crux.noAbout REC Silicon REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine 30 years of experience and proprietary technology with the needs of our customers, and annual production capacity of more than 20,000 MT of polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock Exchange (ticker: REC), the company is headquartered in Fornebu, Norway.For...

Continue reading

Unaudited consolidated interim accounts for the fourth quarter and twelve months of 2020

In the fourth quarter of 2020, the consolidated unaudited sales revenue of Tallinna Kaubamaja Grupp was 201.3 million euros, which was 4.5% more than the sales revenue of the same period in 2019. The sales revenue in the twelve months was 741.9 million euros, showing a growth of 3.4% compared to the result of 2019, when the sales revenue was 717.2 million euros. In the fourth quarter of 2020, the Group’s unaudited consolidated net profit was 8.0 million euros, which was 45.6% weaker than the profit of the comparable period in the previous year. The Group’s net profit in 2020 was 19.5 million euros, which is 38.6% lower than the previous year. The pre-tax profit earned in twelve months was 24.0 million euros, showing a 36.4% decrease compared to last year.The fourth quarter began in a relatively positive economic environment, but returned...

Continue reading

2020. aasta IV kvartali ja 12 kuu auditeerimata majandustulemused

Tallinna Kaubamaja Grupi 2020. aasta neljanda kvartali konsolideeritud auditeerimata müügitulu oli 201,3 miljonit eurot, ületades sellega aasta varasemat müügitulu 4,5%. 12 kuu müügitulu oli 741,9 miljonit eurot, kasvades võrreldes 2019. aasta tulemusega, mil müügitulu oli 717,2 miljonit eurot, 3,4%. Grupi 2020. aasta neljanda kvartali konsolideeritud auditeerimata puhaskasum oli 8,0 miljonit eurot, mis on 45,6% nõrgem eelnenud aasta võrreldava perioodi kasumist. Grupi 2020. aasta puhaskasum oli 19,5 miljonit eurot, mis on aasta varasemaga võrreldes 38,6% madalam. Maksueelne kasum oli kaheteistkümnel kuul 24,0 miljonit eurot, kahanedes varasema aastaga võrreldes 36,4%.Suhteliselt positiivses majanduskeskkonnas alanud neljas kvartal pöördus novembris järsult kasvanud koroona-nakatumise tõttu taas ettevaatlikuks. Kauplused on olnud avatud,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.